Patent details
LUC00197 Product Name: fédratinib ou un sel pharmaceutiquement acceptable de celui-ci
Basic Information
- Publication number:
- LUC00197
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP019060219
- Legal Status:
- Expired
- Application number:
- LUC00197
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/20/1514
- Marketing Authorization Type:
- Marketing Authorization Date:
- 08/02/2021
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 23/02/2021
- First Marketing Authorization date:
- 08/02/2021
- Grant date:
- 05/07/2021
- Activation date:
- 26/02/2021
- Publication date:
- 23/02/2021
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 26/02/2026
- SPC Extension Expiration:
- 26/02/2026
- Rejection date:
- Withdrawal date:
Owner
- From:
- 23/02/2021
- Name:
- AstraZeneca AB
- Address:
- -, 151 85 Södertälje, Sweden (SE)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 23/02/2021
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2021/04
- Publication date:
- 08/03/2021
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPC3
- Bulletin edition number:
- 2021/09
- Publication date:
- 03/08/2021
- Description:
- Section E : Supplementary Protection certificates entered into force – IA publication
3
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2021/09
- Publication date:
- 03/08/2021
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 21/01/2025
- Last Annual Fee Paid Number:
- 25
- Last Annual Fee Paid Amount:
- 450 Euro
- Payer:
- ANAQUA SERVICES (ANC. SGA2)
| Filing date | Document type | Number of pages |
|---|---|---|
| 23/02/2021 | Application Form | 3 |
| 05/07/2021 | Certificate | 1 |
| 05/07/2021 | Outgoing Correspondence | 1 |
| 23/02/2021 | Summary of the product caracteristics | 35 |
| 05/07/2021 | Publication | 1 |
| 23/02/2021 | Outgoing Correspondence | 1 |
| 23/02/2021 | Publication | 1 |
| 23/02/2021 | Marketing authorization | 3 |
| 14/04/2021 | MA publication | 10 |